Cogent Biosciences Inc. has granted equity awards to five new employees under its 2020 Inducement Plan. The awards include nonqualified options to purchase a total of 66,700 shares of common stock and 9,700 restricted stock units (RSUs). Each stock option has a 10-year term, with 25% vesting on the first anniversary of the grant date and the remainder vesting in equal monthly installments over the following 36 months. The RSUs vest annually in equal installments over four years from the grant date. Vesting is contingent on continued employment.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cogent Biosciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 9623490) on January 12, 2026, and is solely responsible for the information contained therein.